Golden Seeds — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
EliseAI applies artificial intelligence to streamline operations in housing and healthcare, two industries historically resistant to technological transformation.
AI & Machine LearningEnterprise SoftwareHealthtechPropTechSaaSNew York, US
Minna Song(Founder)inStoyan Stoyanov(Executive Officer, Director)inAndrew Korn(Executive Officer)inKamil Sindi(Director)Tony Stoyanov(Founder)
BoardLouis Schotsky(Director)in
Co-investorsAlpha PartnersAndreessen HorowitzBessemer Venture PartnersFounders Circle CapitalGlade Brook Capital PartnersGolden Seeds Ventures+9 more
Endomedix develops polysaccharide-based biomaterials and medical technology, with a pipeline moving from polysaccharide chemistry toward preclinical testing and clinical trials.
BiotechHealthtechMedical DevicesNew MaterialsMontclair, US
Piyush M.(Founder)inWeiliam Chen(Director)James R. Pastena(Director)John M. Abrahams(Director)Richard Russo(President & CEO)Richard Olson(Director)
Co-investorsCentral Texas Angel NetworkHouston Angel NetworkKeiretsu ForumSymbiotic Ventures
Haven Connect develops software for affordable housing property management, offering tools for waitlist management, online document collection, and automated waiting list updates.
Marketing TechPropTechBerkeley, US
Caroline Caselli(Executive Officer, Director, Promoter)in
BoardDan Kimerling(Director)
Co-investorsSilicon ValleyTechstarsDeciensEqual Opportunity Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














